NG

Ingevity Corporation

NGVTBasic MaterialsNASDAQ

Specialty Chemicals · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.17B
-2.7% YoY
Net Income
-$167.1M
+61.2% YoY
EBITDA
$41.4M
-35.7% YoY
Free Cash Flow
$225.8M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Negative CrossoverHistogram -0.2691, negative momentum
Jul 10 MACD Negative CrossoverHistogram -0.2240, negative momentum
About Ingevity Corporation

Headquartered within the basic materials sector, Ingevity Corporation focuses on Specialty Chemicals services and products. Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and. The $2.66B market capitalization puts NGVT squarely in mid-cap range for its industry. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Key stats
Market Cap$2.66B
Fwd P/E12.88
EPS$-4.29
Beta1.17
52W Change+65.8%
ROE-114.1%
Analysis

The company holds $95.4M in cash, though total debt stands at $1.24B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $225.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -114.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.0% suggests reasonable efficiency in deploying the company's asset base. Revenue has pulled back from $1.67B (2022) to $1.17B (2025), a 30% decline worth watching.

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Ingevity Corporation and its sector.

Links
More Basic Materials stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms